Series B

With its first dedicated private credit fund, Brigade Capital is targeting a complex, underserved market segment to deliver what larger lenders often miss.

YBI's new 'Landing Zone' program offers a free, equity-free path for manufacturing startups, leveraging world-class expertise to enter the US market.

A new report shows the carbon removal market has the tools to fight climate change, but widespread corporate inaction threatens to strand vital projects.

With two high-profile board appointments, Stellaromics signals its ambition to dominate the 3D spatial omics market with its advanced Pyxa™ platform.

With a new flexible, founder-first model, Activation Capital's Frontier BioHealth program aims to bridge the commercialization gap for life sciences startups.

Sun Life and DentaQuest open nominations for their Health Access Hero Awards, offering grants to groups fighting critical health disparities.

iVeena promotes key execs as it prepares for clinical trials of a novel eye drop that could reshape pediatric myopia treatment worldwide.

The frozen potato giant appoints an AB InBev veteran as Executive Chair and a new CFO, signaling a major push for global expansion and shareholder value.

Bermuda insurer Relm adds C-suite leaders from AXIS and Zurich, signaling a strategic push to dominate insurance for AI, crypto, and space tech.

Edtech leader Echo360 targets systemic funding inequities by doubling its grant awards for underserved institutions, fueling AI-powered learning innovation.

ENA Respiratory's INNA-051 nasal spray, a virus-agnostic shield, has begun Phase II trials, offering new hope for high-risk communities.

With a $1.88M prize pool and 788 teams, WEEX's global AI hackathon is a high-stakes stress test for the next generation of automated finance.

With DOE safety validation for its Mark-0 reactor, Antares accelerates its push to power U.S. defense and space missions with advanced nuclear energy.

Nord Anglia Education empowers students to solve real-world problems, from building prosthetics to restoring coral reefs, through a unique metacognitive approach.

Scrum Alliance's new course helps agile teams move beyond activity tracking to prove their real business value with data-driven, outcome-focused metrics.

A new global consortium aims to break the antibiotic R&D logjam, using open science and AI to combat the growing superbug crisis threatening millions.

LiveWorld unveils a new AI roadmap for pharma, promising a safer, human-guided approach to tackle compliance and build trust in a high-risk industry.

An Israeli startup's laser-based processor is making waves in high-performance computing, offering a practical, room-temperature alternative to quantum.

GSK's subsidiary Tesaro inks a deal worth up to $285M with Alteogen to create an under-the-skin version of its cancer drug Jemperli.

Deeplumen's new tool for Google's UCP signals a massive shift to 'agentic commerce,' where AIs shop for you. But are brands ready for this new world?